IPSC
USDCentury Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.615
High
$0.640
Low
$0.585
Volume
1.02M
Company Fundamentals
Market Cap
51.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.90M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress
PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. ((‘Century', NASDAQ:IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in
Chardan Capital Maintains Buy on Century Therapeutics, Lowers Price Target to $6
Chardan Capital analyst Geulah Livshits maintains Century Therapeutics with a Buy and lowers the price target from $7 to $6.
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Patient dosing initiated in Phase 1 CALiPSO-1 trial evaluating CNTY-101 in autoimmune disease; expanding to additional U.S. and European sites following CTA authorizations in Germany, France, and Italy CNTY-308 expected
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.